Vascular calcification in chronic kidney disease: different bricks in the wall?

A high prevalence of vascular calcification (VC) and a high incidence of cardiovascular events are two key complications of chronic kidney disease. Since most observational studies found a positive association between these two complications, a causal relationship has been assumed. If so, this would...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 2017-04, Vol.91 (4), p.808-817
Hauptverfasser: Vervloet, Marc, Cozzolino, Mario
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 817
container_issue 4
container_start_page 808
container_title Kidney international
container_volume 91
creator Vervloet, Marc
Cozzolino, Mario
description A high prevalence of vascular calcification (VC) and a high incidence of cardiovascular events are two key complications of chronic kidney disease. Since most observational studies found a positive association between these two complications, a causal relationship has been assumed. If so, this would render VC a target of therapy. Recent studies, however, suggested this assumption might be an oversimplification. The fundamental aspects of these recent studies are two-fold. The first novel insight is that VC is not a single entity. VC can be the consequence of a wide range of different biological processes, but also of pharmacological interventions. Sometimes it is the underlying process that carries the additional risk, and sometimes it is tissue calcification itself. Both calcium-containing phosphate binders and statin therapy are associated with an increase in VC, but with divergent effects on cardiovascular risk. Moreover, VC can have different anatomical and histological locations. The second novel insight is that the assumption of a straightforward linear association between the amount of VC and risk for clinical events can be challenged. In this review we summarize recent literature that should lead to reconsidering the implications of VC in CKD. This includes an overview of the many different pathways underlying the ultimate occurrence of VC. Finally, we present a nuanced view concerning the pathophysiologic and therapeutic implications of the different types of calcification in patients with chronic kidney disease.
doi_str_mv 10.1016/j.kint.2016.09.024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1846026691</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253816305531</els_id><sourcerecordid>1846026691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-dc8a974437412794eab547851191e1c7545ff5c22e4acddc777c8002b73fd8713</originalsourceid><addsrcrecordid>eNp9kE1PwzAMhiMEYmPwBzigHrm0JGnStAgJoYkvadIuwDXKHFfL1rUjaUH797Ta4MjJtvT4lf0QcslowijLblbJ2tVtwvs-oUVCuTgiYyZ5GjMl5TEZU5rLmMs0H5GzEFa0n4uUnpIRVwUTimZjMv8wAbrK-AhMBa50YFrX1JGrI1j6pnYQrZ2tcRdZF9AEvO2bskSPdRstvIN1GNh2idG3qar7c3JSmirgxaFOyPvT49v0JZ7Nn1-nD7MYBKVtbCE3hRIiVYL1xwg0CylULhkrGDJQUsiylMA5CgPWglIKckr5QqWlzRVLJ-R6n7v1zWeHodUbFwCrytTYdEGzXGSUZ1kxoHyPgm9C8FjqrXcb43eaUT2I1Cs9iNSDSE0L3Yvsl64O-d1ig_Zv5ddcD9ztAey__HLodQCHNaB1HqHVtnH_5f8AUA-DvQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1846026691</pqid></control><display><type>article</type><title>Vascular calcification in chronic kidney disease: different bricks in the wall?</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ)</source><source>Alma/SFX Local Collection</source><creator>Vervloet, Marc ; Cozzolino, Mario</creator><creatorcontrib>Vervloet, Marc ; Cozzolino, Mario</creatorcontrib><description>A high prevalence of vascular calcification (VC) and a high incidence of cardiovascular events are two key complications of chronic kidney disease. Since most observational studies found a positive association between these two complications, a causal relationship has been assumed. If so, this would render VC a target of therapy. Recent studies, however, suggested this assumption might be an oversimplification. The fundamental aspects of these recent studies are two-fold. The first novel insight is that VC is not a single entity. VC can be the consequence of a wide range of different biological processes, but also of pharmacological interventions. Sometimes it is the underlying process that carries the additional risk, and sometimes it is tissue calcification itself. Both calcium-containing phosphate binders and statin therapy are associated with an increase in VC, but with divergent effects on cardiovascular risk. Moreover, VC can have different anatomical and histological locations. The second novel insight is that the assumption of a straightforward linear association between the amount of VC and risk for clinical events can be challenged. In this review we summarize recent literature that should lead to reconsidering the implications of VC in CKD. This includes an overview of the many different pathways underlying the ultimate occurrence of VC. Finally, we present a nuanced view concerning the pathophysiologic and therapeutic implications of the different types of calcification in patients with chronic kidney disease.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1016/j.kint.2016.09.024</identifier><identifier>PMID: 27914706</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Arteries - metabolism ; Arteries - pathology ; Arteries - physiopathology ; arteriosclerosis ; Biomarkers - blood ; cardiovascular disease ; chronic kidney disease ; Comorbidity ; coronary calcification ; Humans ; Incidence ; mineral metabolism ; Prevalence ; Prognosis ; Renal Insufficiency, Chronic - blood ; Renal Insufficiency, Chronic - diagnosis ; Renal Insufficiency, Chronic - epidemiology ; Renal Insufficiency, Chronic - therapy ; Risk Assessment ; Risk Factors ; Signal Transduction ; vascular calcification ; Vascular Calcification - blood ; Vascular Calcification - diagnosis ; Vascular Calcification - epidemiology ; Vascular Calcification - therapy</subject><ispartof>Kidney international, 2017-04, Vol.91 (4), p.808-817</ispartof><rights>2016 International Society of Nephrology</rights><rights>Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-dc8a974437412794eab547851191e1c7545ff5c22e4acddc777c8002b73fd8713</citedby><cites>FETCH-LOGICAL-c400t-dc8a974437412794eab547851191e1c7545ff5c22e4acddc777c8002b73fd8713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27914706$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vervloet, Marc</creatorcontrib><creatorcontrib>Cozzolino, Mario</creatorcontrib><title>Vascular calcification in chronic kidney disease: different bricks in the wall?</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>A high prevalence of vascular calcification (VC) and a high incidence of cardiovascular events are two key complications of chronic kidney disease. Since most observational studies found a positive association between these two complications, a causal relationship has been assumed. If so, this would render VC a target of therapy. Recent studies, however, suggested this assumption might be an oversimplification. The fundamental aspects of these recent studies are two-fold. The first novel insight is that VC is not a single entity. VC can be the consequence of a wide range of different biological processes, but also of pharmacological interventions. Sometimes it is the underlying process that carries the additional risk, and sometimes it is tissue calcification itself. Both calcium-containing phosphate binders and statin therapy are associated with an increase in VC, but with divergent effects on cardiovascular risk. Moreover, VC can have different anatomical and histological locations. The second novel insight is that the assumption of a straightforward linear association between the amount of VC and risk for clinical events can be challenged. In this review we summarize recent literature that should lead to reconsidering the implications of VC in CKD. This includes an overview of the many different pathways underlying the ultimate occurrence of VC. Finally, we present a nuanced view concerning the pathophysiologic and therapeutic implications of the different types of calcification in patients with chronic kidney disease.</description><subject>Animals</subject><subject>Arteries - metabolism</subject><subject>Arteries - pathology</subject><subject>Arteries - physiopathology</subject><subject>arteriosclerosis</subject><subject>Biomarkers - blood</subject><subject>cardiovascular disease</subject><subject>chronic kidney disease</subject><subject>Comorbidity</subject><subject>coronary calcification</subject><subject>Humans</subject><subject>Incidence</subject><subject>mineral metabolism</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Renal Insufficiency, Chronic - blood</subject><subject>Renal Insufficiency, Chronic - diagnosis</subject><subject>Renal Insufficiency, Chronic - epidemiology</subject><subject>Renal Insufficiency, Chronic - therapy</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Signal Transduction</subject><subject>vascular calcification</subject><subject>Vascular Calcification - blood</subject><subject>Vascular Calcification - diagnosis</subject><subject>Vascular Calcification - epidemiology</subject><subject>Vascular Calcification - therapy</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1PwzAMhiMEYmPwBzigHrm0JGnStAgJoYkvadIuwDXKHFfL1rUjaUH797Ta4MjJtvT4lf0QcslowijLblbJ2tVtwvs-oUVCuTgiYyZ5GjMl5TEZU5rLmMs0H5GzEFa0n4uUnpIRVwUTimZjMv8wAbrK-AhMBa50YFrX1JGrI1j6pnYQrZ2tcRdZF9AEvO2bskSPdRstvIN1GNh2idG3qar7c3JSmirgxaFOyPvT49v0JZ7Nn1-nD7MYBKVtbCE3hRIiVYL1xwg0CylULhkrGDJQUsiylMA5CgPWglIKckr5QqWlzRVLJ-R6n7v1zWeHodUbFwCrytTYdEGzXGSUZ1kxoHyPgm9C8FjqrXcb43eaUT2I1Cs9iNSDSE0L3Yvsl64O-d1ig_Zv5ddcD9ztAey__HLodQCHNaB1HqHVtnH_5f8AUA-DvQ</recordid><startdate>201704</startdate><enddate>201704</enddate><creator>Vervloet, Marc</creator><creator>Cozzolino, Mario</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201704</creationdate><title>Vascular calcification in chronic kidney disease: different bricks in the wall?</title><author>Vervloet, Marc ; Cozzolino, Mario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-dc8a974437412794eab547851191e1c7545ff5c22e4acddc777c8002b73fd8713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Arteries - metabolism</topic><topic>Arteries - pathology</topic><topic>Arteries - physiopathology</topic><topic>arteriosclerosis</topic><topic>Biomarkers - blood</topic><topic>cardiovascular disease</topic><topic>chronic kidney disease</topic><topic>Comorbidity</topic><topic>coronary calcification</topic><topic>Humans</topic><topic>Incidence</topic><topic>mineral metabolism</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Renal Insufficiency, Chronic - blood</topic><topic>Renal Insufficiency, Chronic - diagnosis</topic><topic>Renal Insufficiency, Chronic - epidemiology</topic><topic>Renal Insufficiency, Chronic - therapy</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Signal Transduction</topic><topic>vascular calcification</topic><topic>Vascular Calcification - blood</topic><topic>Vascular Calcification - diagnosis</topic><topic>Vascular Calcification - epidemiology</topic><topic>Vascular Calcification - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vervloet, Marc</creatorcontrib><creatorcontrib>Cozzolino, Mario</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vervloet, Marc</au><au>Cozzolino, Mario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vascular calcification in chronic kidney disease: different bricks in the wall?</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2017-04</date><risdate>2017</risdate><volume>91</volume><issue>4</issue><spage>808</spage><epage>817</epage><pages>808-817</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><abstract>A high prevalence of vascular calcification (VC) and a high incidence of cardiovascular events are two key complications of chronic kidney disease. Since most observational studies found a positive association between these two complications, a causal relationship has been assumed. If so, this would render VC a target of therapy. Recent studies, however, suggested this assumption might be an oversimplification. The fundamental aspects of these recent studies are two-fold. The first novel insight is that VC is not a single entity. VC can be the consequence of a wide range of different biological processes, but also of pharmacological interventions. Sometimes it is the underlying process that carries the additional risk, and sometimes it is tissue calcification itself. Both calcium-containing phosphate binders and statin therapy are associated with an increase in VC, but with divergent effects on cardiovascular risk. Moreover, VC can have different anatomical and histological locations. The second novel insight is that the assumption of a straightforward linear association between the amount of VC and risk for clinical events can be challenged. In this review we summarize recent literature that should lead to reconsidering the implications of VC in CKD. This includes an overview of the many different pathways underlying the ultimate occurrence of VC. Finally, we present a nuanced view concerning the pathophysiologic and therapeutic implications of the different types of calcification in patients with chronic kidney disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27914706</pmid><doi>10.1016/j.kint.2016.09.024</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0085-2538
ispartof Kidney international, 2017-04, Vol.91 (4), p.808-817
issn 0085-2538
1523-1755
language eng
recordid cdi_proquest_miscellaneous_1846026691
source MEDLINE; Free E-Journal (出版社公開部分のみ); Alma/SFX Local Collection
subjects Animals
Arteries - metabolism
Arteries - pathology
Arteries - physiopathology
arteriosclerosis
Biomarkers - blood
cardiovascular disease
chronic kidney disease
Comorbidity
coronary calcification
Humans
Incidence
mineral metabolism
Prevalence
Prognosis
Renal Insufficiency, Chronic - blood
Renal Insufficiency, Chronic - diagnosis
Renal Insufficiency, Chronic - epidemiology
Renal Insufficiency, Chronic - therapy
Risk Assessment
Risk Factors
Signal Transduction
vascular calcification
Vascular Calcification - blood
Vascular Calcification - diagnosis
Vascular Calcification - epidemiology
Vascular Calcification - therapy
title Vascular calcification in chronic kidney disease: different bricks in the wall?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A19%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vascular%20calcification%20in%20chronic%20kidney%20disease:%20different%20bricks%20in%20the%20wall?&rft.jtitle=Kidney%20international&rft.au=Vervloet,%20Marc&rft.date=2017-04&rft.volume=91&rft.issue=4&rft.spage=808&rft.epage=817&rft.pages=808-817&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1016/j.kint.2016.09.024&rft_dat=%3Cproquest_cross%3E1846026691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1846026691&rft_id=info:pmid/27914706&rft_els_id=S0085253816305531&rfr_iscdi=true